Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9931536.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care.
Medical subject headings
- Immunoglobulins, Intravenous
- Myasthenia Gravis